Homologous recombination repair gene mutation (HRRm) testing patterns and treatment selection from a real-world cohort of patients with metastatic castration-resistant prostate cancer (mCRPC).

被引：0
|
作者：
Shore, Neal D.
Craver, Christopher
Blanc, Simon
Sathyan, Pratheesh
Aton, Lindsay
Varughese, Prateesh
Tierno, Marni Brisson
机构：
[1] Carolina Urol Res Ctr, Myrtle Beach, SC USA
[2] Integra Connect, W Palm Beach, FL USA
[3] Integra Connect PrecisionQ, W Palm Beach, FL USA
[4] Illumina Inc, San Diego, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 4_SUPPL期
关键词：
283-2494-5577-2829-12292; 613-225-3248-9542-9243; 130-544; 613-4678-416-5229; 298-11050; 3282-206-4957-326-2356-4994; 9; 7; 6; 3; 2; 109; 1; 38092-20446; 38092-18438; 38092-35367; 38092-20212; 38092-18853;
D O I：
10.1200/JCO.2024.42.4_suppl.210
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：210 / 210
页数：1
相关论文
共 50 条
  • [21] Exploiting defects in homologous recombination repair for metastatic, castration-resistant prostate cancer
    Chau, Vincent
    Madan, Ravi A.
    Figg, William D.
    CANCER BIOLOGY & THERAPY, 2020, 21 (10) : 884 - 887
  • [22] Real-world practice patterns in veterans with metastatic castration-resistant prostate cancer
    Halwani, Ahmad S.
    Rasmussen, Kelli M.
    Patil, Vikas
    Li, Catherine C.
    Yong, Christina M.
    Burningham, Zachary
    Gupta, Sumati
    Narayanan, Sujata
    Lin, Shih-Wen
    Carroll, Susheela
    Mhatre, Shivani K.
    Graff, Julie N.
    Dreicer, Robert
    Sauer, Brian C.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (01) : 1.e1 - 1.e10
  • [23] Central, prospective detection of homologous recombination repair gene mutations (HRRm) in tumour tissue from >4000 men with metastatic castration-resistant prostate cancer (mCRPC) screened for the PROfound study
    de Bono, J. S.
    Fizazi, K.
    Saad, F.
    Shore, N.
    Sandhu, S. K.
    Mehra, N.
    Kolinsky, M.
    Roubaud, G.
    Ozguroglu, M.
    Matsubara, N.
    Gedye, C.
    Choi, Y. D.
    Padua, C.
    Goessl, C.
    Kohlmann, A.
    Corcoran, C.
    Adelman, C. A.
    Allen, A.
    Burgents, J.
    Hussain, M.
    ANNALS OF ONCOLOGY, 2019, 30 : 328 - +
  • [24] Real-World Treatment Patterns Among Patients With Metastatic Castration-Resistant Prostate Cancer: Results From an International Study
    Barata, Pedro C.
    Leith, Andrea
    Ribbands, Amanda
    Montgomery, Rachel
    Last, Matthew
    Arondekar, Bhakti
    Ivanova, Jasmina
    Niyazov, Alexander
    ONCOLOGIST, 2023, 28 (09): : E737 - E747
  • [25] Real-world homologous recombination repair (HRR) mutation testing patterns in patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC) in the United States (US).
    Barata, Pedro C.
    Montgomery, Rachel
    Last, Matthew
    Gillespie-Akar, Liane
    Nazari, Jonathan
    Niyazov, Alexander
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [26] Real-world treatment patterns in French metastatic castration-resistant prostate cancer patients under abiraterone or enzalutamide
    Scailteux, L. M.
    Vincendeau, S.
    Gravis, G.
    Mathieu, R.
    Balusson, F.
    Kerbrat, S.
    Oger, E.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2023, 37 : 10 - 11
  • [27] Centralized screening for homologous recombination repair (HRR) genes in metastatic castration-resistant prostate cancer (mCRPC): A feasibility study from a multicenter Spanish cohort
    Freire, J.
    Caramelo, B.
    Duran Martinez, I.
    del Carmen, S.
    Azueta, A.
    Garcia-Berbel, P.
    Diaz, P. D.
    Cacho Lavin, D.
    Orellana, M.
    Lencina, M.
    Mordillo, C.
    Gomez, J.
    ANNALS OF ONCOLOGY, 2023, 34 : S991 - S992
  • [28] Real-world treatment patterns and overall survival among men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) in the US Medicare population
    Freedland, Stephen J.
    Davis, Matthew
    Epstein, Andrew J.
    Arondekar, Bhakti
    Ivanova, Jasmina I.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2024, 27 (02) : 327 - 333
  • [29] Response to olaparib or carboplatin in a real-world cohort of men with DNA damage repair (DDR) deficient metastatic castration-resistant prostate cancer (mCRPC)
    Berchuck, Jacob E.
    Silver, Rebecca
    Bakouny, Ziad
    Abou Alaiwi, Sarah
    Hamid, Anis
    Sweeney, Christopher
    Freedman, Matthew L.
    Pomerantz, Mark
    Taplin, Mary-Ellen
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [30] Real-world treatment patterns and overall survival among men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) in the US Medicare population
    Stephen J. Freedland
    Matthew Davis
    Andrew J. Epstein
    Bhakti Arondekar
    Jasmina I. Ivanova
    Prostate Cancer and Prostatic Diseases, 2024, 27 : 327 - 333
12345